rich 1.0 Today's BioPharm Brief highlights advances in neurology, hematology, and nephrology, featuring new Alzheimer's disease biomarker data, an expanded pediatric approval for von Willebrand disease prophylaxis, and the first dual BAFF and APRIL inhibitor approved for IgA nephropathy. The BioPharm Brief https://audioboom.com/channels/5167274-the-biopharm-brief Audioboom https://audioboom.com 480 95 https://audioboom.com/i/43732789/600x600/c 600 600 <iframe width="100%" height="95" src="https://embeds.audioboom.com/posts/8925408/embed?v=202301" style="background-color: transparent; display: block; padding: 0; width: 100%" frameborder="0" allowtransparency="allowtransparency" scrolling="no" title="Audioboom player" allow="autoplay" sandbox="allow-downloads allow-forms allow-popups allow-same-origin allow-scripts allow-storage-access-by-user-activation allow-top-navigation-by-user-activation"></iframe>